Sanofi (SNY) Cash & Equivalents Growth (5y) (2014 - 2025)

Sanofi (SNY) Cash & Equivalents Growth (5y) (2014 - 2025) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Sanofi	-	-	9.49 Bn

Historic Data

Download Data

Date	Value
Dec 31, 2025	-11.69%
Jun 30, 2025	-0.23%
Dec 31, 2024	-5.29%
Jun 30, 2024	-0.69%
Dec 31, 2023	3.46%
Jun 30, 2023	-73.88%
Dec 31, 2022	1.36%
Jun 30, 2022	-9.25%
Dec 31, 2021	0.82%
Jun 30, 2021	-79.10%
Dec 31, 2020	10.60%
Jun 30, 2020	27.62%
Dec 31, 2019	2.61%
Jun 30, 2019	5.10%
Dec 31, 2018	-6.80%
Jun 30, 2018	320.30%
Dec 31, 2017	7.97%
Jun 30, 2017	16.66%
Dec 31, 2016	14.82%
Jun 30, 2016	399.95%